APOL1-MEDIATED KIDNEY DISEASE

Clinical trials for APOL1-MEDIATED KIDNEY DISEASE explained in plain language.

Never miss a new study

Get alerted when new APOL1-MEDIATED KIDNEY DISEASE trials appear

Sign up with your email to follow new studies for APOL1-MEDIATED KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets genetic cause of kidney failure

Disease control Recruiting now

This study is testing an investigational drug called AZD2373 to see if it can slow kidney damage in people with a specific genetic form of kidney disease (APOL1-mediated). About 96 adults with the high-risk APOL1 genes will receive either the drug or a placebo for at least 30 wee…

Matched conditions: APOL1-MEDIATED KIDNEY DISEASE

Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

APOL1-MEDIATED KIDNEY DISEASE

Get alerted when new APOL1-MEDIATED KIDNEY DISEASE trials appear

New drug trial targets genetic cause of kidney failure